Clinical Trial Detail

NCT ID NCT04128423
Title Study of AMV564 in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amphivena Therapeutics, Inc.
Indications

Advanced Solid Tumor

Therapies

AMV-564

Age Groups: adult senior

No variant requirements are available.